Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer

PURPOSE: Lapatinib, a small molecule EGFR/HER2 inhibitor, has limited effect on outgrowth of HER2+ brain metastases in preclinical and clinical trials. We investigated the ability of lapatinib to reach therapeutic concentrations in the CNS following (14)C-lapatinib administration (100 mg/kg p.o. or...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Taskar, Kunal S., Rudraraju, Vinay, Mittapalli, Rajendar K., Samala, Ramakrishna, R. Thorsheim, Helen, Lockman, Julie, Gril, Brunilde, Hua, Emily, Palmieri, Diane, Polli, Joseph W., Castellino, Stephen, Rubin, Stephen D., Lockman, Paul R., Steeg, Patricia S., Smith, Quentin R.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2011
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3489161/
https://ncbi.nlm.nih.gov/pubmed/22011930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-011-0601-8
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items